Could AVIVA PLC ADRS – UNSPONSORED UNITED KIN (OTCMKTS:AVVIY) Skyrocket? The Stock Has Too Many Sellers

June 17, 2018 - By Darrin Black

The stock of AVIVA PLC ADRS – UNSPONSORED UNITED KIN (OTCMKTS:AVVIY) registered an increase of 17.59% in short interest. AVVIY’s total short interest was 38,100 shares in June as published by FINRA. Its up 17.59% from 32,400 shares, reported previously. With 131,200 shares average volume, it will take short sellers 0 days to cover their AVVIY’s short positions.

The stock decreased 2.12% or $0.29 during the last trading session, reaching $13.41. About 32,511 shares traded. Aviva plc (OTCMKTS:AVVIY) has 0.00% since June 17, 2017 and is . It has underperformed by 12.57% the S&P500.

Aviva plc provides life insurance, general insurance, accident and health insurance, and asset management services and products worldwide. The company has market cap of $26.93 billion. The companyÂ’s long-term insurance and savings products include Annuities; equity release products; pension products, such as personal and group pensions, stakeholder pensions, and income drawdown; protection products, including term assurance, mortgage life insurance, flexible whole of life, and critical illness cover and group schemes; bonds and savings comprising single premium investment bonds and regular premium savings plans; and investment products consisting of unit trusts, individual savings accounts, and open ended investment companies. It has a 14.61 P/E ratio. The Company’s general and health insurance products comprise personal lines of insurance products, such as motor, household, travel, and creditor insurance; commercial lines of insurance products, including fleet, liability, and commercial property insurance; health insurance products consisting of private health, income protection, and personal accident products, as well as various corporate healthcare insurance products; and insurance for corporate and specialty risks.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.